Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Interim Results

25 Jan 2019 10:16

RNS Number : 1397O
Marechale Capital PLC
25 January 2019
Β 

25 January 2019

Β 

Marechale Capital plc

("Marechale Capital" or the "Company")

Β 

Interim Results

Β 

Marechale Capital plc today announces its unaudited interim results for the six months ended 31 October 2018.

Β 

Chairman's Statement

Β 

I report poor operating results for the first half which are broadly in line with the same period last year: revenues of Β£136,000 (2017: Β£125,000); and an operating loss of Β£(251,000) (2017 Β£(279,000)). The Company's net loss of Β£(184,000) (2017: Β£(460,000)) is after taking into account a gain of Β£67,000 on the realisation of one investment and in 2017, making a provision against the fair value of options held in investee companies of Β£119,000 and a provision for project loss in an associate of Β£63,000. Whilst our current deal flow remains strong, a number of the transactions we are involved in are taking longer to complete.

Β 

Marechale Capital is highly selective about the management teams, as well as the companies, it advises and backs with its investor relationships. On a more positive note this long-term strategy has resulted inΒ 2018 being the Company's best year for exits with 5 multiple investor return exits and one write-off. Successful exits include the Sheen Falls Lodge, West Country Renewables and Inn Collection and more details on these, and the other transactions, can be found on our website.

Β 

The Board of Marechale Capital continues to consider its options and its future strategy.

Β 

Β 

Mark Warde-Norbury

Chairman

Β 

Β 

Β 

For further information please contact:

Β 

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

Β 

Tel: +44 (0)20 7628 5582

Cenkos Securities

Azhic Basirov / David Jones

Tel: +44 (0)20 7397 8900

Β 

Β 

Β 

Consolidated Income Statement (unaudited)

Β 

Β 

6 months ended

Β 

Β 

Β 

Β 

31 October

31 October

Β 

Β 

Β 

Β 

Β 

2018

2017

Β 

Β 

Β 

Β 

Β 

Β£

Β£

Revenue

Β 

Β 

Β 

Β 

136,491

125,066

Cost of sales

Β 

Β 

Β 

Β 

(61,611)

(44,370)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Gross profit

Β 

Β 

Β 

Β 

74,880

80,696

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Administrative expenses

Β 

Β 

Β 

(325,927)

(358,988)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Operating (loss)

Β 

Β 

Β 

(251,047)

(278,291)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Investment revenues

Β 

Β 

Β 

67,389

-

Other (losses)

Provision for project loss in associate

Β 

Β 

Β 

-

(118,5000)

(63,000)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(Loss) before tax

Β 

Β 

Β 

(183,658)

(459,791)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Taxation

Β 

Β 

Β 

Β 

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(Loss) for the period

Β 

(183,658)

(459,791)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(Loss) per share

Β 

Β 

Β 

(Pence)

(Pence)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

- Basic

Β 

(0.32)

(0.69)

Β 

- Diluted

Β 

Β 

Β 

(0.32)

(0.69)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Consolidated Balance Sheet (unaudited)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

As at

Β 

Β 

Β 

Β 

31 October

31 October

Β 

Β 

Β 

Β 

Β 

Β 

2018

2017

Β 

Β 

Β 

Β 

Β 

Β 

Β£

Β£

Β 

Non current assets

Β 

Β 

Β 

Β 

Β 

Β 

Investment in associate

Β 

Β 

Β 

14,038

14,187

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Current assets

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Available for sale investments

Β 

Β 

107,087

153,341

Β 

Trading investments

Β 

Β 

Β 

78,388

78,388

Β 

Trade and other receivables

Β 

Β 

80,485

69,894

Β 

Cash and cash equivalents

Β 

Β 

63,172

98,110

Β 

Β 

Β 

Β 

Β 

Β 

329,132

399,734

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total assets

Β 

Β 

Β 

Β 

343,170

413,921

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Current liabilities

Β 

Β 

Β 

Β 

Β 

Β 

Trade and other payables

Β 

Β 

Β 

(117,107)

(125,596)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total current liabilities

Β 

Β 

Β 

(117,107)

(125,596)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net assets

Β 

Β 

Β 

Β 

226,063

288,325

Β 

Β 

Equity

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Capital and reserves attributable to equity shareholders

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Share capital

Β 

Β 

Β 

Β 

461,449

461,449

Β 

Revaluation reserve

Β 

Β 

Β 

25,826

81,826

Β 

Reserve for own shares

Β 

Β 

Β 

(50,254)

(50,254)

Β 

Retained losses

Β 

Β 

Β 

(210,958)

(289,150)

Β 

Reserve for share based payments

Β 

Β 

Β 

-

84,453

Β 

Β 

Β 

Β 

Β 

Β 

226,063

288,325

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Consolidated Cash Flow Statement (unaudited)

Β 

Β 

Β 

Β 

Β 

Β 

6 months ended

31 October

31 October

Β 

Β 

Β 

Β 

Β 

2018

2017

Β 

Β 

Β 

Β 

Β 

Β£

Β£

Net cash from operating activities

Β 

Β 

Β 

Β 

Operating loss

Β 

(251,047)

(278,291)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Operating cash flows before movements in working capital

(251,047)

(278,291)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Movement in working capital

Β 

Β 

Β 

Β 

Decrease in receivables

Β 

Β 

120,689

151,781

(Decrease) in payables

Β 

Β 

(4,239)

(77,755)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

116,450

74,026

Β 

Β 

Β 

Β 

Β 

Β 

Operating cash flow

Β 

Β 

Β 

(134,597)

(204,265)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Investment activities

Β 

Β 

Β 

Β 

Β 

Proceeds on disposal of available for sale investments

91,529

-

Expenditure on available for sale investments

Other

Β 

(12,700)

600

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flow from investing activities

Β 

Β 

79,429

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Financing

Β 

Β 

Β 

Β 

Β 

Β 

Issue of share capital

Β 

Β 

Β 

-

-

Interest payable

Β 

Β 

Β 

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flow from financing activities

Β 

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net decrease) in cash and cash equivalents

Β 

(55,168)

(204,265)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents at start of the period

118,340

302,375

Cash and cash equivalents at end of the period

63,172

98,110

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(Decrease) in cash and cash equivalents

Β 

(55,168)

(204,265)

Β 

Β 

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
IR CKPDKKBKDDDB
Date   Source Headline
9th Nov 20112:50 pmRNSHolding(s) in Company
22nd Sep 201111:20 amRNSResult of AGM
20th Sep 201110:03 amRNSDirector/PDMR Shareholding
25th Aug 20119:46 amRNSFinal Results
18th Apr 20111:44 pmRNSDirector/PDMR Shareholding
14th Apr 20112:16 pmRNSHolding(s) in Company
12th Apr 20117:00 amRNSDirectorate Change
31st Mar 20113:28 pmRNSIssue of Equity
29th Mar 20113:17 pmRNSDirectorate Appointment & Dealing
28th Mar 20113:39 pmRNSDirector/PDMR Shareholding
16th Mar 20119:20 amRNSDirector/PDMR Shareholding
25th Feb 20113:46 pmRNSHolding(s) in Company
9th Feb 20112:02 pmRNSDirector/PDMR Shareholding
19th Jan 20111:34 pmRNSDirector/PDMR Shareholding
13th Jan 20114:19 pmRNSHolding(s) in Company
11th Jan 201112:27 pmRNSDirector/PDMR Shareholding
15th Dec 201012:00 pmRNSHalf Yearly Report
29th Sep 20103:06 pmRNSResult of AGM
22nd Sep 201010:34 amRNSDirector/PDMR Shareholding
7th Sep 201012:00 pmRNSFinal Results and Notice of General Meeting
17th Mar 20109:00 amRNSChange of Adviser
22nd Feb 20103:15 pmRNSResult of GM
12th Feb 201012:00 pmRNSDirector/PDMR Shareholding
4th Feb 201011:00 amRNSDirector/PDMR Shareholding
29th Jan 201012:00 pmRNSNotice of General Meeting
12th Jan 20107:00 amRNSApplication for New Ordinary Shares
23rd Dec 20092:31 pmRNSHalf Yearly Report
17th Dec 20095:15 pmRNSResult of AGM
7th Dec 200912:28 pmRNSHoldings in Company / Directors Dealings
23rd Nov 20097:00 amRNSAcquisition and AGM
23rd Oct 20099:17 amRNSHolding in Company
15th Oct 20092:41 pmRNSChange of Name of Nominated Adviser and Broker
30th Sep 20094:00 pmRNSAnnual Report & Accounts
18th Sep 20097:00 amRNSNotifiable Interests
18th Sep 20097:00 amRNSHolding in Company
28th Aug 20092:30 pmRNSAcquisition of Whim Gully Capital LLP
28th Aug 20092:30 pmRNSPreliminary Results and Notice of General Meeting
21st Jul 20097:00 amRNSDisposal
6th Aug 200810:59 amRNSDirector/PDMR Shareholding
23rd Jun 20087:00 amRNSAppointment of joint broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.